PRESIDE: PReventing the EffectS of Intubation on DEglutition

Sponsor
Johns Hopkins University (Other)
Overall Status
Recruiting
CT.gov ID
NCT02442102
Collaborator
National Institute on Deafness and Other Communication Disorders (NIDCD) (NIH)
40
1
1
89
0.4

Study Details

Study Description

Brief Summary

An early intervention for swallowing disorders (i.e., dysphagia) during endotracheal intubation may improve patient outcomes. The investigators propose treatment sessions targeting sensorimotor integration, strength, and range of motion during oral endotracheal intubation with mechanical ventilation to reduce or prevent dysphagia and aspiration (food or liquids entering the airway), establish a solid foundation in understanding reasons for swallowing impairment after extubation from mechanical ventilation and learn new methods to reduce or prevent these problems.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Exercise and sensory stimulation
N/A

Detailed Description

The overall goals of this study are to evaluate patients with acute respiratory failure from the time they are orally intubated in the ICU to: 1) investigate tongue weakness and other pathophysiological aspects of dysphagia, and 2) evaluate, in a Phase II clinical trial, a novel, multimodal, sensorimotor intervention conducted during intubation to reduce or prevent dysphagia after extubation. Patients who are expected to be intubated with mechanical ventilation for >96 hours will be consecutively enrolled shortly after intubation. Laryngeal function, tongue strength, swallowing pathophysiology, and breathing-swallowing coordination will be evaluated with valid and reliable standardized measures. While orally intubated, patients in the treatment group will receive a novel, early, sensorimotor intervention for 60-minutes daily, 5 times per week, targeting improved swallowing physiology and kinematics to reduce aspiration and dysphagia. These daily sessions will continue until the completion of a modified barium swallow study conducted within approximately 2 days after extubation, and thereafter standard clinical care will resume. Patients in the control group will receive standard clinical care during intubation and throughout their hospital stay. All patients will be followed to hospital discharge to determine the pathophysiological and clinical impact of the proposed intervention. Knowledge from this study will provide important data for this novel intervention and provide a critical foundation for understanding the physiological mechanisms of dysphagia and aspiration after intubation in patients with acute respiratory failure. With success, this investigation will help shift clinical practice patterns to consider early intervention with the goal of reducing the frequency and severity of swallowing impairment leading to aspiration and additional medical complications.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Understanding and Improving Dysphagia After Mechanical Ventilation
Study Start Date :
Jul 1, 2015
Anticipated Primary Completion Date :
Dec 1, 2022
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Exercise and sensory stimulation

60-minute sessions with sensory electrical stimulation (SES) applied 5 days per week with oromotor exercises completed when patient is able to participate

Behavioral: Exercise and sensory stimulation
60-minute sessions with sensory electrical stimulation (SES) applied 5 days per week with oromotor exercises completed when patient is able to participate
Other Names:
  • VitalStim (Chattanooga Group; Hixson, TN)
  • Outcome Measures

    Primary Outcome Measures

    1. Number of participants aspirating during fiberoptic endoscopic swallow study [participants will be evaluated an expected average of 48 hours after extubation]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 100 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • ≥18 years old

    • Required mechanical ventilation via an oral endotracheal tube

    Exclusion Criteria:
    • Unable to understand or speak English due to a language barrier

    • Unable to understand or speak English due to a cognitive impairment

    • Barium sulfate allergy

    • Pregnancy

    • Presence of any cardiac pacing device (including temporary epicardial pacing) without an underlying cardiac rhythm as confirmed by treating physician or diaphragmatic pacer

    • Nasal endotracheal intubation during the present admission

    • Patient is not expected to require ≥48 hours of intubation

    • Pre-existing dysphagia/aspiration, voice or cognitive disorder

    • Reflux with history of known or suspected aspiration

    • Presence of a central nervous system, neuromuscular or connective tissue disease (e.g., stroke, Guillain-Barre, scleroderma)

    • Active seizure disorder

    • Pain disorder of the jaw muscles or mandibular joint

    • Ever tracheotomy or prior endotracheal intubation other than for surgery (≤ 1 year)

    • Head and/or neck disease (e.g., oropharyngeal cancer)

    • Head and/or neck surgery other than tonsillectomy

    • Known or suspected anatomical abnormalities or pre-intubation trauma of the oral cavity, pharynx, larynx, or esophagus

    • Known or suspected sleep apnea (treated or untreated)

    • Prior major thoracic surgery (e.g., sternotomy, thoracotomy)

    • Unplanned (e.g., self- or accidental) extubation or re-intubation before consent

    • Weight exceeds capacity of the radiology equipment

    • Expected tracheostomy tube placement while in hospital

    • Moribund (>90% probability of mortality in hospital), based on ICU team's assessment

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Johns Hopkins Hospital Baltimore Maryland United States 21287

    Sponsors and Collaborators

    • Johns Hopkins University
    • National Institute on Deafness and Other Communication Disorders (NIDCD)

    Investigators

    • Principal Investigator: Martin B Brodsky, PhD, ScM, Johns Hopkins University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Johns Hopkins University
    ClinicalTrials.gov Identifier:
    NCT02442102
    Other Study ID Numbers:
    • IRB00029289
    • 1K23DC013569-01
    First Posted:
    May 13, 2015
    Last Update Posted:
    Dec 8, 2021
    Last Verified:
    Dec 1, 2021
    Keywords provided by Johns Hopkins University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Dec 8, 2021